Medicare billing address
CMS Medicare provider billing file
2760 Century BlvdWyomissing, PA 19610
CMS public data · NPI 1245394295
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Saurin Mehta, MD
Specialty
Credential
MD
NPI
1245394295
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Saurin Mehta, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2760 Century BlvdCMS Doctors & Clinicians file
2000 Westinghouse DrCMS Doctors & Clinicians file
2760 Century BlvdIn the 2024 CMS provider billing file, this NPI had 817 Medicare beneficiaries and 346,302 total services. The average beneficiary age was 74, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$3,543,434.97
Total Medicare payment amount
$2,806,374.10
Medicare beneficiaries
817
Total services
346,302
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Osteoporosis
60%
CMS beneficiary-panel share
Anxiety
33%
CMS beneficiary-panel share
Diabetes
25%
CMS beneficiary-panel share
Ischemic heart disease
23%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, tocilizumab, 1 mg | 166,001 | $5.92 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 79,400 | $4.53 |
| Injection, romosozumab-aqqg, 1 mg | 36,330 | $10.75 |
| Injection, denosumab, 1 mg | 17,400 | $25.31 |
| Injection, golimumab, 1 mg, for intravenous use | 14,800 | $11.03 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13,775 | $41.64 |
| Injection, infliximab, excludes biosimilar, 10 mg | 5,204 | $29.30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,226 | $0.98 |
| Injection of drug or substance under skin or into muscle | 1,029 | $13.49 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 941 | $121.08 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1245394295. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Methotrexate | Methotrexate Sodium | 413 | 935.4 | $11,033.99 |
| 2 | Prednisone | Prednisone | 391 | 660.1 | $3,588.88 |
| 3 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 355 | 765.8 | $14,438.59 |
| 4 | Alendronate Sodium | Alendronate Sodium | 324 | 865.8 | $3,029.82 |
| 5 | Tramadol Hcl | Tramadol Hcl | 307 | 330 | $3,184.74 |
| 6 | Gabapentin | Gabapentin | 214 | 395.4 | $2,757.94 |
| 7 | Allopurinol | Allopurinol | 169 | 436.7 | $2,266.57 |
| 8 | Duloxetine Hcl | Duloxetine Hcl | 161 | 331 | $3,192.37 |
| 9 | Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 93 | 93 | $2,090.98 |
| 10 | Nortriptyline Hcl | Nortriptyline Hcl | 57 | 91 | $595.72 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Temple University School Of Medicine
Graduation year
2003
Group/practice field
Phoenix Rehabilitation And Health Services Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.